Fund+
Venture capital
UncertainLast verified 12 Nov 2026
Fund+ is an open-ended venture fund making long-term equity investments in innovative life sciences companies, primarily focused on Belgium.
2 deals in the last 24 months, latest 3 Nov 2025. Derived from its deals in the news.
Key facts
- Stages
- Series A, Series C+
- Sectors
- Biotech & pharma
- Eligible countries
- Belgium
- Provider based in
- Belgium
- Timing
- Rolling applications
- Focus
- innovative Life Sciences companies; focus on Belgium
- How to apply
- Application form · Apply on their site
- Source
- https://fundplus.be/
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| Tubulis | Series C+ | Biotech & pharma, Healthtech | €344M | participant | 3 Nov 2025 |
| Coave Therapeutics | Series A | Biotech & pharma | €32M | participant | 9 Jan 2025 |
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Apply link
https://fundplus.be/project | Your Project
https://fundplus.be/ - Kind
Fund+ is an open-ended Fund for long term equity investment in innovative Life Sciences companies
https://fundplus.be/ - Sectors
long term equity investment in innovative Life Sciences companies
https://fundplus.be/
Status history
- 12 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Is something out of date?
Suggest an editTakes 10 seconds
Something else wrong? Report an error.
Work at Fund+? Claim this profile to confirm what you invest in.